Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurosci.

Sec. Neurodegeneration

Volume 19 - 2025 | doi: 10.3389/fnins.2025.1629830

APOE4-APP interactions exert early influences on cerebrovascular structure and function: Implications for Alzheimer's Disease

Provisionally accepted
Lanboling  GuoLanboling Guo1Jessica  R GauntJessica R Gaunt1Calvin  Chee Hoe CheahCalvin Chee Hoe Cheah1Albert  I. ChenAlbert I. Chen2Stephanie  ClaudineStephanie Claudine3Gavin  DaweGavin Dawe3Eyleen  Lay Keow GohEyleen Lay Keow Goh1Sok-Hong  KhoSok-Hong Kho3Pawan  KumarPawan Kumar3Grace  G Y LimGrace G Y Lim1Kah-Leong  LimKah-Leong Lim1Yun-An  LimYun-An Lim3Takaomi  SaidoTakaomi Saido4Takashi  SaitoTakashi Saito5Hiroki  SasaguriHiroki Sasaguri6Judy  CG SngJudy CG Sng3Yee  Jie YeapYee Jie Yeap1Alaric  K K YipAlaric K K Yip1Norliyana  ZainolabidinNorliyana Zainolabidin1Toh Hean  Ch'ngToh Hean Ch'ng1George  J. AugustineGeorge J. Augustine1,7*
  • 1Neuroscience & Mental Health Program, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, Singapore
  • 2School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
  • 3Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  • 4RIKEN Center for Brain Science, Saitama, Japan, Saitama, Japan
  • 5Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • 6Dementia Pathophysiology Collaboration Unit, RIKEN Center for Brain Science, Wako, Japan
  • 7Temasek Life Sciences Laboratory, Singapore, Singapore

The final, formatted version of the article will be published soon.

Background: APOE4 and APP are two of the main genetic risk factors for Alzheimer's disease (AD). Although there have been suggestions that these two factors interact, most of the in vivo evidence for such interactions comes from transgenic mouse models that suffer from complications associated with protein overexpression. Our goal was to examine the consequences of interactions between APOE4 and APP on brain function while avoiding the use of transgenic mice. Methods: We generated and characterized double-mutant knock-in mice incorporating familial APP mutations and humanized APOE4. Results: In the brains of 3-month-old double-mutant mice there were significant alterations in vascular remodeling genes, vascular structure and blood-brain barrier permeability. These changes were not observed in either APOE4 or APP single-mutant mice and, thus, were caused by interactions between the two genes. These interaction effects were transient, because they were absent in 8-month-old double-mutant mice. Conclusions: These findings indicate that early vascular changes, driven by the interaction of APP and APOE4, may influence the progression of AD. Our work highlights the need to focus on the synergistic vascular actions of APOE4 and APP, particularly at younger ages.

Keywords: ApoE4, APP, Dementia, Transcriptomics, cerebral vasculature

Received: 16 May 2025; Accepted: 22 Sep 2025.

Copyright: © 2025 Guo, Gaunt, Cheah, Chen, Claudine, Dawe, Goh, Kho, Kumar, Lim, Lim, Lim, Saido, Saito, Sasaguri, Sng, Yeap, Yip, Zainolabidin, Ch'ng and Augustine. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: George J. Augustine, george_augustine@tll.org.sg

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.